div style=”text-align: justify;”CSFB is out with new (negative) info onspan style=”font-weight: bold;” Apollo Group (NASAQ:APOL)/span noting the shares rallied yesterday in reaction, they believe, to news of the dismissal of the lawsuit filed December in Arkansas alleging that Apollo wrongfully returned Title IV funds to the Department of Education to manage down cohort default rates; they think some investors had believed that the dismissal meant that the issue had been put to bed.br /br /span style=”font-weight: bold;”Industry sources lead CSFB to think that the lawsuit is likely to be refiled in the coming days in Phoenix./spanbr /br /span style=”font-weight: bold;”Although they expect news of a refiling to weigh on APOL shares short term and potentially increase volatility in coming weeks,/span they continue to like APOL shares and would view significant weakness as a buying opportunity. Sector history makes the firm think that, even if some wrongdoing were found by the Department of Education, resulting financial penalties would not likely be large enough to materially hurt Apollo’s enterprise value as long as Apollo worked with the Department to ensure compliance going forward.br /br /Further, they are optimistic that 09 enrollment and earnings upside (vs CS and consensus ests) may result from the combination of the weak economy and continued expense management initiatives.br /br /span style=”color: rgb(255, 0, 0); font-weight: bold;”Notablecalls:/span This is new info. Kudos to CSFB people. In light of this I’m calling APOL an ACTIONABLE SHORT. I’m surprised they didn’t downgrade the stock.br /br /span style=”font-weight: bold; color: rgb(255, 0, 0);”I think the stock can go below $84 level this. /spanbr //div

Last 5 posts by Notable Calls

• Petroquest Energy (NYSE:PQ): Compelling Valuation with Near-Term Catalysts; Upgrading to Overweight - J.P. Morgan - October 29th, 2009
• 15% correction coming in SP500? - October 21st, 2009
• Boeing (NYSE:BA): Downgraded to Underweight at Morgan Stanley, target to $43 - October 20th, 2009
• Par Pharmaceuticals (NYSE:PRX): Upgraded to Overweight at Barclays; target raised to $30 - October 15th, 2009
• Wyndham Worldwide (NYSE:WYN): Upgraded to Buy at Goldman Sachs; $26 target established - October 7th, 2009